Moreover, increasing drug
resistance coupled with the high drug attrition rate is engendering the
requirement for extensive R&D activities, which is presumed to boost the
adoption of structural biology & molecular modeling techniques in the drug
discovery and development process. This is expected to serve as an efficient
approach in fast tracking the development of drugs with high potency.
The heightening demand for
molecular modeling techniques is predominantly attributable to the significant
cost reduction enabled. This is due to the fact that prediction software
identifies possible adverse reactions and determines drug efficacy and toxicity
in the pre-clinical stages, thereby reducing the probability of drug failure at
the later stages. Consequentially, the aforementioned factors serve as
prominent reasons responsible for the widened market demand.
Full
Research Report On structural biology &
molecular modeling techniques market Analysis:
http://www.grandviewresearch.com/industry-analysis/structural-biology-and-molecular-modeling-technique-market
http://www.grandviewresearch.com/industry-analysis/structural-biology-and-molecular-modeling-technique-market
Further key findings from the study
suggest:
·
SaaS & standalone modeling
held the largest share of the tools segment in 2015 owing to extensive
utilization of computer-assisted structuring and modeling techniques in R&D
·
The drug discovery segment is
anticipated to grow at a lucrative CAGR owing to continual introduction of
software modifications with focus on enhanced drug designing aimed to
accelerate the process in identifying novel therapeutic agents
·
In 2015, North America
dominated the global structural biology & molecular modeling techniques
market owing to the presence of a wide number of established pharmaceutical
companies extensively involved in the commercialization of in silico tools to promote
their usage
·
Asia Pacific is expected to
grow at an exponential CAGR owing to favorable government initiatives
supporting research activities and the increasing trend of outsourcing drug
development by the developed economies
·
The key participants are employing
clinical and research collaborative strategies promoting the adoption of
structural prediction software and databases to gain a competitive advantage
View More Reports of This Category by Grand
View Research At: https://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has
segmented the structural biology & molecular modeling techniques market on
the basis of tools, applications, and region:
Tools Outlook (Revenue, USD Million, 2014 -
2025)
·
SaaS & standalone modeling
o Homology modeling
o Threading
o Molecular dynamics
o Ab Initio
o Hybrid
o Others
·
Visualization & analysis
·
Databases
·
Others
Application Outlook (Revenue, USD Million,
2014 - 2025)
·
Drug development
·
Drug discovery
·
Others
Regional Outlook (Revenue, USD Billion,
2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o UK
o Germany
·
Asia Pacific
o Japan
o China
o India
·
Latin America
o Mexico
o Brazil
·
MEA
o South Africa
Access
Full Press Release of this Report:
https://www.grandviewresearch.com/press-release/global-structural-biology-molecular-modeling-technique-market
https://www.grandviewresearch.com/press-release/global-structural-biology-molecular-modeling-technique-market
About
Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more
information: https://www.grandviewresearch.com/
